Vimeo
LinkedIn
Instagram
Share |

Boehringer Ingelheim

April 24, 2012

Much of Europe might be experiencing austerity, but some family businesses are reporting strong growth.

Much of Europe might be experiencing austerity, but some family businesses are reporting strong growth.

A German family-owned pharmaceutical company, Boehringer Ingelheim, said on 24 April that revenues for 2011 rose by 6.2% to €13.2 billion.

Much of this growth was due to the sale of prescription medicines, which accounted for 77% of total turnover, said the Ingelheim-based group.

Click here >>
Close